Eric Van der Putten, Modra Pharmaceuticals - Oral Taxane Therapy | LSI Europe '24

Developing oral taxane therapies with fewer severe side effects to improve cancer patients' lives.
Speakers
Eric van
Eric van
Chief Business Officer, Modra Pharmaceuticals